13F HOLDINGS REPORT
First Turn Management, LLC
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001993440-25-000004
Total Value
$666.0M
Positions
29
Other Managers
0
Confidential Omitted
No
Holdings (29)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | INSMED INC | INSM | 319,773 | $46.1M | 6.91% |
| 2 | MIRUM PHARMACEUTICALS INC | MIRM | 570,569 | $41.8M | 6.28% |
| 3 | UNITED THERAPEUTICS CORP DEL | UTHR | 85,318 | $35.8M | 5.37% |
| 4 | MERUS N V | N5749R100 | 372,022 | $35.0M | 5.26% |
| 5 | NUVALENT INC | NUVL | 394,754 | $34.1M | 5.13% |
| 6 | XENON PHARMACEUTICALS INC | XENE | 799,743 | $32.1M | 4.82% |
| 7 | BRIDGEBIO PHARMA INC | BBIO | 589,729 | $30.6M | 4.60% |
| 8 | REVOLUTION MEDICINES INC | RVMDW | 643,050 | $30.0M | 4.51% |
| 9 | ASCENDIS PHARMA A/S | ASND | 146,291 | $29.1M | 4.37% |
| 10 | ARGENX SE | ARGX | 38,767 | $28.6M | 4.29% |
| 11 | DISC MEDICINE INC | IRON | 397,693 | $26.3M | 3.95% |
| 12 | ORIC PHARMACEUTICALS INC | ORIC | 2,159,474 | $25.9M | 3.89% |
| 13 | ARCELLX INC | ACLX | 313,733 | $25.8M | 3.87% |
| 14 | NEUROCRINE BIOSCIENCES INC | NBIX | 181,897 | $25.5M | 3.83% |
| 15 | ABIVAX SA | AAVXF | 291,820 | $24.8M | 3.72% |
| 16 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 716,971 | $20.4M | 3.06% |
| 17 | AKERO THERAPEUTICS INC | 00973Y108 | 397,010 | $18.9M | 2.83% |
| 18 | AXSOME THERAPEUTICS INC | AXSM | 152,614 | $18.5M | 2.78% |
| 19 | ENLIVEN THERAPEUTICS INC | ELVN | 783,411 | $16.0M | 2.41% |
| 20 | APOGEE THERAPEUTICS INC | APGE | 402,811 | $16.0M | 2.40% |
| 21 | KYMERA THERAPEUTICS INC | KYMR | 277,726 | $15.7M | 2.36% |
| 22 | JANUX THERAPEUTICS INC | JANX | 639,699 | $15.6M | 2.35% |
| 23 | ROIVANT SCIENCES LTD | ROIV | 959,703 | $14.5M | 2.18% |
| 24 | CYTOKINETICS INC | CYTK | 254,795 | $14.0M | 2.10% |
| 25 | NATERA INC | NTRA | 80,875 | $13.0M | 1.95% |
| 26 | ADMA BIOLOGICS INC | ADMA | 808,673 | $11.9M | 1.78% |
| 27 | VERA THERAPEUTICS INC | VERA | 354,529 | $10.3M | 1.55% |
| 28 | HARROW INC | HROW | 160,234 | $7.7M | 1.16% |
| 29 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 262,643 | $1.9M | 0.28% |